Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
Chronic granulomatous disease (CGD) is a severe inborn error of immunity caused by NADPH oxidase defects. Here, we develop CRISPR/Cas9-based gene editing strategies for correction of variants in the CYBA and CYBB genes causing CGD. For X-linked CGD, we also develop a near-universal gene editing strategy by targeted integration of a truncated CYBB cDNA in CD34<sup>+</sup> hematopoietic stem and progenitor cells (HSPCs). Throughout, off-target editing and chromosomal translocations are evident, which negatively impact the ability of gene-edited HSPCs to engraft in immunodeficient mice. However, by employing a high-fidelity Cas9 to minimize off-target editing, we demonstrate restoration of the multilineage engraftment potential of gene-edited HSPCs. Moreover, to further improve safety, we develop a D10A Cas9n editing approach with no detectable off-target activity or chromosomal translocations. Collectively, through risk assessments of different gene editing approaches, we present a D10A Cas9n-based strategy with improved safety, offering a potentially curative treatment for CGD patients.
Authors
- Thomas Wisbech Skov (ORCID: https://orcid.org/0009-0008-0959-880X)
- Sofie E. Jørgensen (ORCID: https://orcid.org/0000-0002-2700-0882)
- Rasmus Otkjær Bak (ORCID: https://orcid.org/0000-0002-7383-0297)
- Didde Haslund (ORCID: https://orcid.org/0000-0002-9890-5814)
- Martin Kristian Thomsen (ORCID: https://orcid.org/0000-0002-5055-7531)
- Anne Louise Revenfeld (ORCID: https://orcid.org/0000-0003-1840-0259)
- Bjarne Kuno Møller (ORCID: https://orcid.org/0000-0003-2808-4755)
- Trine Hyrup Mogensen (ORCID: https://orcid.org/0000-0002-1853-9704)
- Jonas Holst Wolff (ORCID: https://orcid.org/0000-0001-5690-7603)
- Mette Holm (ORCID: https://orcid.org/0000-0002-9159-4056)
- Sandra Ammann (ORCID: https://orcid.org/0000-0003-0385-1890)
- Jacob Giehm Mikkelsen (ORCID: https://orcid.org/0000-0002-1322-3209)
- Toni Cathomen (ORCID: https://orcid.org/0000-0002-7757-4630)
- Sofie Rahbek Dorset
- Clotilde Aussel
Institutions
- University of Freiburg (DE)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1038/s41467-025-62738-2
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aarhus Universitet
- Innovationsfonden
- Deutsche Forschungsgemeinschaft
- Carlsbergfondet
- Novo Nordisk
- Novo Nordisk Fonden